Literature DB >> 15680407

Preliminary studies on DNA retardation by MutS applied to the detection of point mutations in clinical samples.

Anna Stanisławska-Sachadyn1, Zygmunt Paszko, Anna Kluska, Elzbieta Skasko, Maria Sromek, Aneta Bałabas, Aneta Janiec-Jankowska, Alicja Wiśniewska, Józef Kur, Paweł Sachadyn.   

Abstract

MutS ability to bind DNA mismatches was applied to the detection of point mutations in PCR products. MutS recognized mismatches from single up to five nucleotides and retarded the electrophoretic migration of mismatched DNA. The electrophoretic detection of insertions/deletions above three nucleotides is also possible without MutS, thanks to the DNA mobility shift caused by the presence of large insertion/deletion loops in the heteroduplex DNA. Thus, the method enables the search for a broad range of mutations: from single up to several nucleotides. The mobility shift assays were carried out in polyacrylamide gels stained with SYBR-Gold. One assay required 50-200 ng of PCR product and 1-3 microg of Thermus thermophilus his6-MutS protein. The advantages of this approach are: the small amounts of DNA required for the examination, simple and fast staining, no demand for PCR product purification, no labelling and radioisotopes required. The method was tested in the detection of cancer predisposing mutations in RET, hMSH2, hMLH1, BRCA1, BRCA2 and NBS1 genes. The approach appears to be promising in screening for unknown point mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15680407     DOI: 10.1016/j.mrfmmm.2004.10.001

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  2 in total

1.  A Colorimetric Microplate Assay for DNA-Binding Activity of His-Tagged MutS Protein.

Authors:  Michał Banasik; Paweł Sachadyn
Journal:  Mol Biotechnol       Date:  2016-09       Impact factor: 2.695

2.  A simple modification of PCR thermal profile applied to evade persisting contamination.

Authors:  Michał Banasik; Anna Stanisławska-Sachadyn; Paweł Sachadyn
Journal:  J Appl Genet       Date:  2016-01-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.